FT ENEMA READY TO USE TWIN PAK
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORMStrength
7; 19 g/118mL; g/118mL
Manufacturer
McKessonNDC
70677108902
Classification
Generic
Dosage Form
ENEMA
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
5/2/2023
Price Statistics
The NADAC for FT ENEMA READY TO USE TWIN PAK has been published 113 times since Aug 7, 2024, and over the history we have for it it has risen 9.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0072 per ML |
|---|---|
| All-time high | $0.0072 (Sep 30, 2026) |
| All-time low | $0.0065 (Sep 18, 2024) |
| 52-week high | $0.0072 |
| 52-week low | $0.0066 |
| Median price | $0.0066 |
| Average price | $0.0066 |
| Largest weekly change | +2.4% (Jun 17, 2026) |
| Weeks tracked | 113 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
McKesson manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ENEMA READY TO USE TWIN PAK?
The current National Average Drug Acquisition Cost (NADAC) for FT ENEMA READY TO USE TWIN PAK, manufactured by McKesson, is $0.0072 per ML (NDC 70677108902), effective Sep 30, 2026.
How has the price of FT ENEMA READY TO USE TWIN PAK changed over time?
Over the history we have for it, the NADAC for FT ENEMA READY TO USE TWIN PAK has risen 9.2%. It has been tracked across 113 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for FT ENEMA READY TO USE TWIN PAK?
Since Aug 7, 2024, the NADAC for FT ENEMA READY TO USE TWIN PAK has ranged from a low of $0.0065 (Sep 18, 2024) to a high of $0.0072 (Sep 30, 2026), with a median of $0.0066 per ML.
Are there cheaper alternatives to FT ENEMA READY TO USE TWIN PAK?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ENEMA READY TO USE, is $0.0067 per ML — about 6% below FT ENEMA READY TO USE TWIN PAK.
Who manufactures FT ENEMA READY TO USE TWIN PAK?
FT ENEMA READY TO USE TWIN PAK (NDC 70677108902) is labeled by McKesson, and CMS classifies it as a generic product.